Buy Loteprednol (Lotemax) eye drops online
Loteprednol (trade names include Lotemax, Alrex, Loteflam, Lotepred, Loteprol, Lotesoft, Oftol Forte) is an ophthalmological antiinflammatory medication from corticosteroids pharmacological group. This medicine is used for the treatment of swelling and redness caused by certain eye conditions or surgery. Ocular applications for Loteprednol include the therapy of inflammation of the eye due to allergies, as well as chronic forms of keratitis (such as adenoviral and Thygeson's keratitis), pingueculitis, vernal keratoconjunctivitis, and episcleritis. Lotemax eye drops has little or no effect on intraocular pressure.
How and where to order Loteprednol (Lotemax) eye drops online:
Shop: BUY LOTEPREDNOL ONLINE
Prices: from $12.99 per bottle
Forms: Loteprednol Etabonate (Lotemax) 0.5% 5 ml ophthalmic solution
Quantity: 1-6 bottles
Type: Lotemax (Loteprednol) generic
Payment: Visa, MasterCard, AmEx, Bitcoin
Delivery: AirMail, Trackable courier
Shipping: Worldwide, including USA, UK, Europe, Canada, Australia
Bimatoprost (Latisse, Lumigan)
Dorzolamide, Timolol Maleate (Cosopt)
Fluocinolone Acetonide (Dermotic)
Unoprostone Isopropyl (Rescula)
Pharmacological and medical categories:
Eye care medications
S - Sensory organs
S01 - Ophthalmologicals
S01B - Antiinflammatory agents
S01BA - Corticosteroids, plain
S01BA14 - Loteprednol
Other inflammation of eyelid - H01
Conjunctivitis - H10
Pingueculitis - H10.81
Disorders of sclera - H15
Keratitis - H16
Vernal keratoconjunctivitis, with limbar and corneal involvement - H16.26
Other specified disorders of eye and adnexa - H57.8
C - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
Brands, generics, trade names:
Alrex - Bausch and Lomb
Loteflam - Cipla
Lotemax - Bausch and Lomb, Hyphens Pharma, Invida, U.S. Summit
Lotepred - Sun Pharmaceutical Industries
Lotepred-LS - Sun Pharmaceutical Industries
Loteprol - Bausch and Lomb
Loterex - Bausch and Lomb
Lotesoft - Poen Laboratorios
Oftol - Saval Laboratorios
Oftol Forte - Saval Laboratorios
APIs used in medicine in combinations with loteprednol:
Indications and usage:
Lotemax (Loteprednol Etabonate) eye drops are indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.
Lotemax is less effective than prednisolone acetate 1% in two 28-day controlled clinical studies in acute anterior uveitis, where 72% of patients treated with Loteprednol experienced resolution of anterior chamber cells, compared to 87% of patients treated with prednisolone acetate 1%. The incidence of patients with clinically significant increases in IOP ( >= 10 mmHg) was 1% with Lotemax and 6% with prednisolone acetate 1%. This medication should not be used in patients who require a more potent corticosteroid for this indication.
Loteprednol is also indicated for the treatment of post-operative inflammation following ocular surgery.
Lotemax (Loteprednol Etabonate) ophthalmic solution, as with other ophthalmic corticosteroids, is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. Lotemax is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation. Steroids should be used with caution in the presence of glaucoma.
Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infections. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids.
In acute purulent conditions of the eye, steroids may mask infection or enhance existing infection.Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution.
The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.
Information for Patients
This product is sterile when packaged. Patients should be advised not to allow the dropper tip to touch any surface, as this may contaminate the suspension. If pain develops, redness, itching or inflammation becomes aggravated, the patient should be advised to consult a physician. As with all ophthalmic preparations containing benzalkonium chloride, patients should be advised not to wear soft contact lenses when using Lotemax (Loteprednol).
Dosage and administration:
Shake vigorously before using Lotemax (Loteprednol) eye drops.
Steroid Responsive Disease Treatment
Apply one to two drops of Lotemax into the conjunctival sac of the affected eye four times daily. During the initial treatment within the first week, the dosing may be increased, up to 1 drop every hour, if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after two days, the patient should be re-evaluated.
Apply one to two drops of Lotemax into the conjunctival sac of the operated eye four times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period.
Adverse reactions, side effects:
Reactions associated with ophthalmic steroids such as Loteprednol include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.
Ocular adverse reactions occurring in 5%-15% of patients treated with loteprednol etabonate ophthalmic suspension (0.2%-0.5%) in clinical studies included abnormal vision/blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia. Other ocular adverse reactions occurring in less than 5% of patients include conjunctivitis, corneal abnormalities, eyelid erythema, keratoconjunctivitis, ocular irritation/pain/discomfort, papillae, and uveitis. Some of these events were similar to the underlying ocular disease being studied.
Non-ocular adverse reactions occurred in less than 15% of patients. These include headache, rhinitis and pharyngitis.
Updated: February 2020
Reviewed: February 2020
Doctors all across the world have relied on Florida Eye Equipment to fulfill their equipment needs.
For additional information please contact our office via e-mail at firstname.lastname@example.org or our national (USA) toll-free telephone number at 1-800-336-0410.
Florida Eye Equipment
2833 Highway 92 East
Lakeland, Fl 33801
Phone: (863) 666-5057
Toll Free 800-336-0410
Fax: (863) 666-1311
Buying & Selling New & Pre Owned Ophthalmic Equipment Since 1989